Time since last use of oral contraceptives and risk of invasive cervical cancer

European Journal of Cancer

Volumn 34, Issue 6, 1998, Pages 884-888

  Parazzini, F ^a,b   Chatenoud, L ^a   La Vecchia, G ^a,c   Chiaffarino, F ^a   Ricci, E ^a   Negri, E ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Cervical cancer; Oral contraceptives; Risk factors

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; DRUG CARCINOGENICITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AGE FACTORS; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; EDUCATIONAL STATUS; FEMALE; HUMANS; MIDDLE AGED; PARITY; RISK FACTORS; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 0032077399     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)10139-3     Document Type: Article

References (24)

1. Brinton LA. Epidemiology of cervical cancer-overview. In Munoz N, Bosch FX, Shah KV, Meheus. A, eds. The Epidemiology of Cervical Cancer and Human Papillomavirus. Lyon, International Agency for Research on Cancer IARC, 1992, 3-23.
2. Brinton LA, Hamman RF, Huggins GR, et al. Sexual and reproductive risk factors for invasive squamous cell cervical cancer. J Natl Cancer Inst 1987, 79, 23-30.
3. Hidesheim A, Reeves WC, Brinton LA, et al. Association of oral contraceptive use and human papillomaviruses in invasive cervical cancer. IntJ Cancer 1990, 45, 860-864.
4. Parazzini F, La Vecchia C, Negri E, Cecchetti G, Fedele L. Reproductive factors and the risk of invasive and intra-epithelial cervical neoplasia. Br J Cancer 1989, 59, 805-809.
5. Pater MM, Hughes GA, Hyslop DE, Nakshatri H, Pater A. Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNA. Nature 1988, 335, 832-835.
6. Zondervan KT, Carpenter LM, Painter R, Vessey MP. Oral contraceptives and cervical cancer-further findings from the Oxford Family Planning Association contraceptive study. Br J Cancer 1996, 73, 1291-1297.
7. Parazzini F, La Vecchia C, Negri E, Maggi R. Oral contraceptive use and invasive cervical cancer. Int J Epidemiol 1990, 19, 259-263.
8. Baker NJ, Neider JA. The GLIM System, Release 3. Oxford, Numerical Algorithms Group, 1978.
9. Parazzini F, Negri E, Ricci E, Franceschi S, La Vecchia C. Correlates of oral contraceptive use in Italian women, 1991-93. Contraception 1996, 54, 101-106.
10. Paganini-Hill A, Ross RK. Reliability of recall of drug usage and other health-related information. Am J Epidemiol 1982, 116, 114-122.
11. Peters RK, Thomas D, Hagan DG, Mack TM, Henderson BE. Risk factors for invasive cervical cancer among latinas and nonlatinas in Los Angeles county. J Natl Cancer Inst 1986, 77, 10631077.
12. Brinton LA, Huggins GR, Lehman HF, et al. Long-term use of oral contraceptives and risk of invasive cervical cancer. Int J Cancer 1986, 38, 339-344.
13. Ebeling K, Nischan P, Schindler Ch. Use of oral contraceptives and risk of invasive cervical cancer in previously screened women. Int J Cancer 1987, 39, 427-430.
14. Irwin KL, Rosero-Bixby L, Oberle MW, et al. Oral contraceptives and cervical cancer risk in Costa Rica. J Am Med Assoc 1988, 259, 59-64.
15. Beral V, Hannaford P, Kay C. Oral contraceptive use and malignancies of the genital tract. Lancet 1988, 127, 1331.
16. Cuzick J, De Stavola B, McCance D, et al. A case-control study of cervix cancer in Singapore. Br J Cancer 1989, 60, 238-243.
17. Brinton LA, Reeves WC, Brenes MM, et al. Oral contraceptive use and risk of invasive cervical cancer. Int J Epidemiol 1990, 19, 4-11.
18. Bosch FX, Munoz N, De Sanjose S, et al. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 1992, 52, 750-758.
19. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Invasive squamous-cell cervical carcinoma and combined oral contraceptives: results from a multinational study. Int J Cancer 1993, 55, 228-236.
20. Eluf-Neto J, Booth M, Munoz N, Bosch FX, Meijer CJLM, Walboomers JMM. Human papillomavirus and invasive cervical cancer in Brazil. Br T Cancer 1994, 69, 114-119.
21. Chan WK, Klock G, Bernard HV. Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia. J Virol/1989, 63, 3261-3269.
22. Pater A, Bayatiour M, Pater MM. Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone orprogestins from oral contraceptives. Am J Obstet Gynec 1990, 162, 1099-1103.
23. Schneider A, Hotz M, Gissmann I. Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. Int J Cancer 1987, 40, 198-201.
24. Monsonego J, Magdelenat H, Catalan F, Coscas Y, Zerat L, Sastre X. Estrogen and progesterone receptors in cervical human papillomavirus related lesions. Int J Cancer 1991, 48, 533-539.